INMED PHARMACEUTICALS INC

Historical 13F Holders

Symbol
INM
CUSIP
457637700
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 457637700 since 12/18/2024, newest first.

Filer % of Class Filed
ADAR1 Capital Management, LLC 13G/A Amendment 1
17.2% 10/7/2026
Event 9/30/2026
Ikarian Capital, LLC 13G
4.2% 8/14/2026
Event 6/30/2026
Vivo Opportunity Fund Holdings, L.P. 13D
21.7% 6/10/2026
Event 5/19/2026
ADAR1 Capital Management, LLC 13G
24.1% 6/5/2026
Event 5/31/2026
Squadron Capital Management LLC 13G
9.8% 5/27/2026
Event 5/19/2026
Sabby Management, LLC 13G
9.9% 1/20/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 20 2.70 M $5.18 M
2026 Q1 9 319 k $206 k
2025 Q4 7 227 k $241 k
2025 Q3 9 304 k $665 k
2025 Q2 8 8.47 k $28.5 k
2025 Q1 6 6.41 k $13.3 k
2024 Q4 6 48.9 k $227 k